InvestorsHub Logo
Followers 52
Posts 3352
Boards Moderated 0
Alias Born 10/26/2013

Re: Ville post# 1767

Tuesday, 09/19/2017 3:50:32 PM

Tuesday, September 19, 2017 3:50:32 PM

Post# of 3283
While I can't wait for the abstract, I have been moderating my excitement for when it does come out. Simple reason is that, as spelled out in the link of your post, late Breaking Abstract data is due by the end of August. We know from the '24th Annual NewsMakers In The Biotech Industry' presentation from Aug 24th that there were 10 patients already being dosed. That doesn't give pozi a lot of time to work any magic or for a write-up of that magic. I mean is it wise to expect the same early outcomes as it showed for the 2 compassionate use pts? I dunno but if it did show similar results for the 5ish pts or so pts they'll probably have data on, it will blow a hole through the SP roof simply because of the effect it would be showing on such few pts or put it another way in knowing that pozi is the real deal.

On a side note, Dr Raj has said that they would submit data on 10 pts to the FDA for Breakthrough status in 1st Q 2018 if the data is good. Well, they've already dosed 10 pts so the clock is ticking on that.